Accuracy of the 15.5-Day G7 iCGM in Adults with Diabetes.
Garg SK, Bailey TS, Castorino K, Christiansen MP, Liljenquist DR, Salazar H, Akturk HK, Gao S, Johnson ML, Beck SE.
Garg SK, et al.
Diabetes Technol Ther. 2025 Jun;27(6):430-438. doi: 10.1089/dia.2025.0139. Epub 2025 Mar 20.
Diabetes Technol Ther. 2025.
PMID: 40108991
Free article.
We evaluated the performance and safety of an investigational 15-day G7 integrated CGM (iCGM; Dexcom) in adults with diabetes. Methods: This prospective, multicenter study enrolled adults (age 18 years) with type 1 diabetes (T1D) or type 2 diabetes (T2D) at six cli …
We evaluated the performance and safety of an investigational 15-day G7 integrated CGM (iCGM; Dexcom) in adults with diabetes. …